The Uromigos

401 Episodes

1. Episode 303: Community GU Oncology

   Published: 3/5/2024
2. Episode 302: Part 2- Adjuvant Therapy in solid tumors

   Published: 2/25/2024
3. Episode 301: Cancer research from a global perspective.

   Published: 2/20/2024
4. Episode 300: Adjuvant PD1 Therapy in Solid Tumours

   Published: 2/11/2024
5. Episode 299: Androgen receptor ligand-directed degrader BMS-986365

   Published: 2/7/2024
6. Episode 298: ASCO GU 2024 Highlights

   Published: 1/31/2024
7. Episode 297: ASCO GU 2024: CONTACT2 Part 2 - The Aftermath

   Published: 1/30/2024
8. Episode 296: ASCO GU 2024: Novel approaches to QOL and belzutifan

   Published: 1/27/2024
9. Episode 295: ASCO GU 2024: Adjuvant Therapy in Renal Cancer

   Published: 1/27/2024
10. Episode 294: ASCO GU 2024: Adjuvant Pembrolizumab in Bladder Cancer

    Published: 1/27/2024
11. Episode 293: ASCO GU 2024: BRCAaway and CONTACT2

    Published: 1/26/2024
12. Episode 292: ASCO GU 2024: HPN328 - A Tri-Specific T Cell Engager in Prostate Cancer

    Published: 1/26/2024
13. Episode 291: ASCO GU 2024: CONTACT2 - Cabozantinib and Atezolizumab in Prostate Cancer

    Published: 1/25/2024
14. Episode 290: ASCO GU 2024 Preview

    Published: 1/17/2024
15. Episode 289: The Uromigos Paper of the Month - TALAPRO2 in Nature Medicine

    Published: 1/15/2024
16. Episode 288: APCCC #3: Controversies around Radiotherapy

    Published: 1/10/2024
17. Episode 287 APCCC: Early Discontinuation of Therapy in HSPC

    Published: 1/4/2024
18. Episode 286: APCCC Prostate Cancer Meeting Overview

    Published: 1/3/2024
19. Episode 285: Holiday Special: Renal Cancer in 2023

    Published: 12/22/2023
20. Episode 284: Tres amigas: Lo más destacado del cáncer en urología en 2023

    Published: 12/21/2023